Improve yield, reduce deviations, and ensure product quality in GxP pharmaceutical manufacturing with real-time, practical Artificial Intelligence (AI)- powered software as a service solutions.
Curia, a global leader in the CDMO space, needed to better utilize its most valuable asset: data. They needed real-time and historical data to reduce variability in four products used to make pharmaceuticals.
Variations in chemical reactions affect production outcomes, causing fluctuations in product yield and quality. For too long, Curia used manual records and Excel sheets, which made it hard to consolidate data from multiple sources for global reporting. And data extraction discrepancies led to empty or inaccurate top-level reports.